Side by side · live prices and performance
Over the past year Eli Lilly is ahead: +60.34% against −19.22% for Novo Nordisk.
| Metric | Eli Lilly | Novo Nordisk |
|---|---|---|
| Price | $1,174.61 | $45.61 |
| Day change | ▼ 0.13% | ▼ 1.41% |
| 1-month | ▲ 2.24% | ▼ 3.12% |
| 6-month | ▲ 11.66% | ▲ 21.79% |
| 1-year | ▲ 60.34% | ▼ 19.22% |
| 52-week high | $1,292.65 | $64.16 |
| 52-week low | $712.05 | $35.12 |
| Currency | USD | USD |
■ Eli Lilly · ■ Novo Nordisk
Both columns use the same live feed and the same closing convention, so the percentages are directly comparable. Performance figures are price return only — they exclude dividends, splits are already adjusted by the data provider, and the two assets may trade in different currencies, which is shown in the table.